ArticleJournal of experimental & clinical cancer research : CR2024

The immunotoxin targeting PRLR increases tamoxifen sensitivity and enhances the efficacy of chemotherapy in breast cancer.

Jiawei Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.